ES8605770A1 - Procedimiento para obtener un polipeptido purificado - Google Patents

Procedimiento para obtener un polipeptido purificado

Info

Publication number
ES8605770A1
ES8605770A1 ES542309A ES542309A ES8605770A1 ES 8605770 A1 ES8605770 A1 ES 8605770A1 ES 542309 A ES542309 A ES 542309A ES 542309 A ES542309 A ES 542309A ES 8605770 A1 ES8605770 A1 ES 8605770A1
Authority
ES
Spain
Prior art keywords
peptides
isolation
preparation
polypeptide
separation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542309A
Other languages
English (en)
Spanish (es)
Other versions
ES542309A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8605770A1 publication Critical patent/ES8605770A1/es
Publication of ES542309A0 publication Critical patent/ES542309A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES542309A 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado Granted ES542309A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES8605770A1 true ES8605770A1 (es) 1985-12-16
ES542309A0 ES542309A0 (es) 1985-12-16

Family

ID=25820510

Family Applications (3)

Application Number Title Priority Date Filing Date
ES542310A Expired ES8605771A1 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542309A Granted ES542309A0 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES542310A Expired ES8605771A1 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido

Country Status (18)

Country Link
US (1) US4668662A (enExample)
EP (1) EP0158986B1 (enExample)
JP (1) JP2552263B2 (enExample)
KR (1) KR930000054B1 (enExample)
AR (1) AR242800A1 (enExample)
AU (1) AU580295B2 (enExample)
CA (1) CA1271298A (enExample)
DE (2) DE3438296A1 (enExample)
DK (1) DK171824B1 (enExample)
ES (3) ES8605771A1 (enExample)
FI (1) FI851521L (enExample)
GR (1) GR850942B (enExample)
HU (1) HU198085B (enExample)
IE (1) IE60581B1 (enExample)
IL (1) IL74948A (enExample)
NO (1) NO851535L (enExample)
PT (1) PT80301B (enExample)
ZA (1) ZA852854B (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
ES2055149T3 (es) * 1985-04-11 1994-08-16 Hoechst Ag Derivado de hirudina.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
FI905825A7 (fi) * 1988-05-27 1990-11-26 Magainin Sciences Inc Amfifiiliset peptidit ja niiden käyttö
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
EP0347376B1 (en) * 1988-06-11 1994-03-23 Ciba-Geigy Ag Novel polypeptides with an anticoagulant activity
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
EP0514464A4 (en) * 1990-02-08 1993-04-28 Magainin Sciences, Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
CA2035917C (en) * 1990-02-13 2001-10-02 John L. Krstenansky Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
EP0533795A4 (en) * 1990-05-14 1993-10-20 Magainin Sciences, Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
JPH05507718A (ja) * 1990-06-27 1993-11-04 マゲイニン　サイエンセズ　インコーポレーテッド 生物活性ペプチドおよびｄｎａギラーゼを阻害する抗生物質よりなる組成物と治療法
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
CA2086243C (en) * 1990-07-24 2001-10-02 John L. Krstenansky Anticoagulant peptides
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
JPH07500342A (ja) * 1991-10-16 1995-01-12 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 生物学的活性ペプチドおよび抗生物質を有する組成物およびこれを用いた治療
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
ES2199963T3 (es) * 1993-06-11 2004-03-01 Merrell Pharmaceuticals Inc. Peptidos trifuncionales antitrombina y antiplaquetarios.
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) * 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
EP0985513B1 (en) 1996-01-31 2003-01-02 Sumitomo Bakelite Company Limited Method of producing epoxy resin-encapsulated semiconductor device
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
EP2365874A1 (en) * 2008-11-19 2011-09-21 Avantor Performance Materials, Inc. New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
IL74948A (en) 1989-09-10
HU198085B (en) 1989-07-28
GR850942B (enExample) 1985-11-25
FI851521A0 (fi) 1985-04-16
ES542310A0 (es) 1985-12-16
KR930000054B1 (ko) 1993-01-06
CA1271298A (en) 1990-07-03
US4668662A (en) 1987-05-26
PT80301B (de) 1987-02-10
EP0158986A3 (en) 1988-09-21
FI851521A7 (fi) 1985-10-19
HUT37806A (en) 1986-02-28
ZA852854B (en) 1985-11-27
AR242800A1 (es) 1993-05-31
DE3587576D1 (de) 1993-10-21
NO851535L (no) 1985-10-21
EP0158986A2 (de) 1985-10-23
IE60581B1 (en) 1994-07-27
ES8605772A1 (es) 1985-12-16
AU4136485A (en) 1985-10-24
JPS60233098A (ja) 1985-11-19
DE3438296A1 (de) 1985-11-07
FI851521L (fi) 1985-10-19
ES542309A0 (es) 1985-12-16
IL74948A0 (en) 1985-08-30
KR850007801A (ko) 1985-12-09
AU580295B2 (en) 1989-01-12
DK173985D0 (da) 1985-04-17
ES8605771A1 (es) 1985-12-16
IE850983L (en) 1985-10-18
EP0158986B1 (de) 1993-09-15
PT80301A (de) 1985-05-01
DK171824B1 (da) 1997-06-23
DK173985A (da) 1985-10-19
JP2552263B2 (ja) 1996-11-06
ES542311A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
ES8605770A1 (es) Procedimiento para obtener un polipeptido purificado
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
EA199700239A1 (ru) Ингибиторы тромбина, основанные на аминокислотной последовательности гирудина
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
PT72191A (de) Verfahren zur herstellung von neue acylpeptide
PT81991B (pt) Processo para a preparacao de derivados peptidicos, analogos a pepestatina, inibidores darenina e das proteases acidas
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
ES2159562T3 (es) Proceso para la fabricacion de 1-desamino-8-d-arginina-vasopresina.
ES8704957A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
ES2076933T3 (es) Nuevos sustratos peptidicos.
ES8707262A1 (es) Procedimiento para la preparacion de un compuesto peptidico util para la fabricacion de vacunas contra la malaria y parala deteccion de enfermedades paludicas.
MX172666B (es) Proceso para separar glicina y decahidrato de sulfato de sodio a partir de una solucion acuosa
ES8403492A1 (es) Procedimiento para la preparacion de derivados de acidos difosfonicos.
ES8104789A1 (es) Procedimiento para la separacion de leucina, isoleucina y valina
JPS5748961A (en) Preparation of 2,4-diaminobenzenesulfonic acid
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
ES2060180T3 (es) Procedimiento de separacion del acido treo-3-((2-aminofenilo)-tio)-2-hidroxi-3-(4-metoxifenilo) propionico.
ES2054942T3 (es) Procedimiento para la determinacion de fructuosaminas.
ATE147268T1 (de) Hypoglycemische peptide
Carsten Actin. Its thiol groups
ES2010974A4 (es) Proceso para la preparacion de almibar de lactosa de alta pureza y elalmibar obtenido
ATE85346T1 (de) Phosphorylierte derivate von cardiodilatin/anfpeptiden.
Wilson Actions on Blood Clotting of Peptide Material in Human Brain: With Special Reference to Enhancement of Antithrombin Activity

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506